DCE@urLAB: A dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data

BMC Bioinformatics

Volumn 14, Issue 1, 2013, Pages

  Ortuño, Juan E ^a,b   Ledesma Carbayo, María J ^a,b   Simões, Rui V ^c   Candiota, Ana P ^a,d   Arús, Carles ^a,d   Santos, Andrés ^a,b  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Animal models; DCE MRI; Fitting; High field MR; IDL; Imaging; Levenberg Marquardt; Pharmacokinetics; Preclinical

Indexed keywords

ANIMAL MODEL; DCE-MRI; FITTING; HIGH FIELD; IDL; LEVENBERG-MARQUARDT; PRECLINICAL;

APPLICATION PROGRAMS; GRAPHICAL USER INTERFACES; IMAGING TECHNIQUES; PHARMACOKINETICS; PIXELS; SOFTWARE TESTING; TOOLS;

MAGNETIC RESONANCE IMAGING;

ANIMALIA;

CONTRAST MEDIUM;

ALGORITHM; ANIMAL; ARTICLE; BRAIN TUMOR; COMPUTER PROGRAM; COMPUTER SIMULATION; DISEASE MODEL; METABOLISM; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REGRESSION ANALYSIS;

ALGORITHMS; ANIMALS; BRAIN NEOPLASMS; COMPUTER SIMULATION; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE IMAGING; MICE; SOFTWARE;

EID: 84886735382     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-14-316     Document Type: Article

References (57)

1. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workmanw P. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Brit J Cancer 2005, 92(9):1599-1610. 10.1038/sj.bjc.6602550, 2362033, 15870830.
2. Yankeelov TE, Gore JC. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2007, 3(2):91-107.
3. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003, 17(5):509-520. 10.1002/jmri.10304, 12720260.
4. Collins DJ, Padhani AR. Dynamic magnetic resonance imaging of tumor perfusion. IEEE Eng Med Biol 2004, 23(5):65-83.
5. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997, 7:91-101. 10.1002/jmri.1880070113, 9039598.
6. Kiessling F, Farhan N, Lichy MP, Vosseler S, Heilmann M, Krix M, Bohlen P, Miller DW, Mueller MM, Semmler W, Fusenig NE, Delorme S. Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia 2004, 6(3):213-223. 10.1593/neo.03394, 1502099, 15153333.
7. Pike MM, Stoops CN, Langford CP, Akella NS, Nabors LB, Gillespie GY. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: sequential small molecule and SPIO dynamic contrast agent MRI. Magn Reson Med 2009, 61(3):615-625. 10.1002/mrm.21931, 3243360, 19235262.
8. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. fundamental concepts. Magn Reson Med 1991, 17(2):357-367. 10.1002/mrm.1910170208, 2062210.
9. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast - a new method for dynamic MR mammography. Magn Reson Med 1995, 33(4):506-514. 10.1002/mrm.1910330408, 7776881.
10. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain-barrier defect by magnetic-resonance-imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990, 16:117-131. 10.1002/mrm.1910160111, 2255233.
11. Yankeelov TE, Luci JJ, Lepage M, Li R, Debusk L, Lin PC, Price RR, Gore JC. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging 2005, 23(4):519-529. 10.1016/j.mri.2005.02.013, 15919597.
12. Weidensteiner C, Rausch M, McSheehy PMJ, Allegrini PR. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T. J Magn Reson Imaging 2006, 24(3):646-656. 10.1002/jmri.20676, 16878308.
13. Kim JH, Im GH, Yang J, Choi D, Lee WJ, Lee JH. Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function. NMR Biomed 2012, 25(4):674-684. 10.1002/nbm.1784, 21954069.
14. Jensen LR, Huuse EM, Bathen TF, Goa PE, Bofin AM, Pedersen TB, Lundgren S, Gribbestad IS. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo H-1 MRS. NMR Biomed 2010, 23:56-65. 10.1002/nbm.1426, 19650073.
15. Cho HJ, Ackerstaff E, Carlin S, Lupu ME, Wang Y, Rizwan A, O'Donoghue J, Ling CC, Humm JL, Zanzonico PB, Koutcher JA. Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia. Neoplasia 2009, 11(3):247-259. 2647727, 19242606.
16. Muruganandham M, Lupu M, Dyke JP, Matei C, Linn M, Packman K, Kolinsky K, Higgins B, Koutcher JA. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T. Mol Cancer Ther 2006, 5(8):1950-1957. 10.1158/1535-7163.MCT-06-0010, 16928815.
17. Yang XY, Liang JC, Heverhagen JT, Jia G, Schmalbrock P, Sammet S, Koch R, Knopp MV. Improving the pharmacokinetic parameter measurement in dynamic contrast-enhanced MRI by use of the arterial input function: theory and clinical application. Magn Reson Med 2008, 59(6):1448-1456. 10.1002/mrm.21608, 18506805.
18. Stefanovski D, Moate PJ, Boston RC. WinSAAM: a windows-based compartmental modeling system. Metabolism 2003, 52(9):1153-1166. 10.1016/S0026-0495(03)00144-6, 14506622.
19. JPKD 3.0, Java PK for Desktop. http://pkpd.kmu.edu.tw/jpkd/.
20. Barrett PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster DM. SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism 1998, 47(4):484-492. 10.1016/S0026-0495(98)90064-6, 9550550.
21. Rausch M, Stoeckli M. BioMap. http://www.maldi-msi.org/.
22. Cetin O. An analysis tool to calculate permeability based on the patlak method. J Med Syst 2012, 36(3):1317-1326. 10.1007/s10916-010-9592-y, 20848166.
23. Daniel P. Barboriak Laboratory, Duke University School of Medicine: Toppcat, T1-weighted Perfusion Imaging Parameter Calculation Toolkit. http://dblab.duhs.duke.edu/modules/dblabs_topcat/.
24. Whitcher B, Schmid VJ. Quantitative analysis of dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging for oncology in R. J Stat Softw 2011, 44(5):1-29.
25. Ferl GZ. DATforDCEMRI: an R package for deconvolution analysis and visualization of DCE-MRI data. J Stat Softw 2011, 44(3):1-18.
26. Keyzer FD, Vandecaveye V, Thoeny H, Chen F, Ni Y, Marchal G, Hermans R, Nuyts S, Landuyt W, Bosmans H. Dynamic Contrast-enhanced and diffusion-weighted MRI for early detection of tumoral changes in single-dose and fractionated radiotherapy: evaluation in a rat rhabdomyosarcoma model. Eur Radiol 2009, 19(11):2663-2671. 10.1007/s00330-009-1451-1, 19504109.
27. Wang HJ, Li JJ, Chen F, Keyzer FD, Yu J, Feng YB, Nuyts J, Marchal G, Ni YC. Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours. Eur Radiol 2010, 20(8):2013-2026. 10.1007/s00330-010-1743-5, 20182730.
28. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cerebr Blood F Met 1983, 3:1-7.
29. U S National Institutes of Health B. ImageJ, Image Processing and Analysis in Java. http://imagej.nih.gov/ij/.
30. R Development Core Team R: A language and Environment for Statistical Computing 2011, Vienna: R Foundation for Statistical Computing, http://www.R-project.org/, R Development Core Team.
31. Orton MR, d'Arcy JA, Walker-Samuel S, Hawkes DJ, Atkinson D, Collins DJ, Leach MO. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI. Phys Med Biol 2008, 53(5):1225-1239. 10.1088/0031-9155/53/5/005, 18296759.
32. Ferl GZ, Xu L, Friesenhahn M, Bernstein LJ, Barboriak DP, Port RE. An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab. Magn Reson Med 2010, 63(5):1366-1375. 10.1002/mrm.22335, 20432307.
33. Bradley DP, Tessier JJ, Lacey T, Scotta M, Jurgensmeier JM, Odedra R, Mills J, Kilburn L, Wedge SR. Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate. Magn Reson Imaging 2009, 27(3):377-384. 10.1016/j.mri.2008.07.021, 18814988.
34. Loveless ME, Lawson D, Collins M, Nadella MVP, Reimer C, Huszar D, Halliday J, Waterton JC, Gore JC, Yankeelov TE. Comparisons of the efficacy of a Jak1/2 Inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology. Neoplasia 2012, 14:54-64. 3281942, 22355274.
35. Kim H, Folks KD, Guo LL, Stockard CR, Fineberg NS, Grizzle WE, George JF, Buchsbaum DJ, Morgan DE, Zinn KR. DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Mol Imaging Biol 2011, 13:94-103. 10.1007/s11307-010-0320-2, 20383593.
36. Yankeelov TE, DeBusk LM, Billheimer DD, Luci JJ, Lin PC, Price RR, Gore JC. Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T. J Magn Reson Imaging 2006, 24(5):1140-1147. 10.1002/jmri.20729, 17024660.
37. Kato Y, Okollie B, Artemov D. Noninvasive H-1/C-13 magnetic resonance spectroscopic imaging of the intratumoral distribution of temozolomide. Magn Reson Med 2006, 55(4):755-761. 10.1002/mrm.20831, 16508914.
38. Artemov D, Solaiyappan M, Bhujwalla ZM. Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors. Cancer Res 2001, 61(7):3039-3044.
39. Luo YP, Jiang F, Cole TB, Hradil VP, Reuter D, Chakravartty A, Albert DH, Davidsen SK, Cox BF, McKeegan EM, Fox GB. A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model. Cancer Chemoth Pharm 2012, 69(4):911-921.
40. Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 1999, 10(3):233-241. 10.1002/(SICI)1522-2586(199909)10:3<233::AID-JMRI3>3.0.CO;2-M, 10508282.
41. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951, 3:1-41.
42. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995, 33(4):564-568. 10.1002/mrm.1910330416, 7776889.
43. Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011, 66(3):735-745. 10.1002/mrm.22861, 21384424.
44. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Cerebr Blood F Met 1991, 15(4):621-628.
45. Haase A, Frahm J, Matthaei D, Hanicke W, Merboldt KD. Flash imaging - rapid NMR imaging using low flip-angle pulses. J Magn Reson 1986, 67(2):258-266.
46. Li X, Rooney WD, Varallyay CG, Gahramanov S, Muldoon LL, Goodman JA, Tagge IJ, Selzer AH, Pike MM, Neuwelt EA, Springer CS. Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination. J Magn Reson 2010, 206(2):190-199. 10.1016/j.jmr.2010.07.004, 2946221, 20674422.
47. Markwardt CB. Non-linear least squares fitting in IDL with MPFIT. c XVIII, Volume 411 2009, 251-254. Quebec: Astronomical Society of the Pacific, Bohlender D, Dowler P, Durand D.
48. Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. J Soc Ind Appl Math 1963, 11(2):431-441.
49. Ahearn TS, Staff RT, Redpath TW, Semple SIK. The use of the Levenberg-Marquardt curve-fitting algorithm in pharmacokinetic modelling of DCE-MRI data. Phys Med Biol 2005, 50(9):N85-N92. 10.1088/0031-9155/50/9/N02, 15843726.
50. Parker GJM, Buckley DL. Tracer kinetic modelling for T1-weighted DCE-MRI. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology, Medical Radiology: Diagnostic, Imaging and Radiation Oncology 2003, 81-92. Berlin: Springer-Verlag, Jackson A, Buckley DL, Parker GJM.
51. Barboriak DP, MacFall JR, Viglianti BL, Dewhirst MW. Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging. J Magn Reson Imaging 2008, 27(6):1388-1398. 10.1002/jmri.21344, 3755278, 18504759.
52. Raymond GM, Butterworth E, Bassingthwaighte JB. JSIM: free software package for teaching physiological modeling and research. FASEB J 2003, 17(4):A390-A390.
53. Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, Kuriyama H, Kuriyama N, Milshteyn N, Roberts T, Wendland MF, DePinho R, Israel MA. Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res 2003, 63(7):1589-1595.
54. Delgado-Goni T, Martin-Sitjar J, Simoes RV, Acosta M, Lope-Piedrafita S, Arús C. Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors. NMR Biomed 2013, 26(2):173-184. 10.1002/nbm.2832, 22814967.
55. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, Turnbull DH. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003, 49(5):848-855. 10.1002/mrm.10446, 12704767.
56. Simoes RV, García-Martín ML, Cerdán S, Arús C. Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia. NMR Biomed 2008, 21(3):251-264. 10.1002/nbm.1188, 17600847.
57. Stoyanova R, Huang K, Sandler K, Cho H, Carlin S, Zanzonico PB, Koutcher JA, Ackerstaff E. Mapping tumor hypoxia in vivo using pattern recognition of dynamic contrast-enhanced MRI data. Trans Oncol 2012, 5(6):437-447.